Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation

Yun-Xin Lu; Qi-Nian Wu; Dong-liang Chen; Le-Zong Chen; Zixian Wang; Chao Ren; Hai-Yu Mo; Chen Ya; Hui Sheng; Ying-Nan Wang; Yun Wang; Jia-Huan Lu; De‐Shen Wang; Zhao-Lei Zeng; Feng Wang; Feng-Hua Wang; Yuhong Li; Huai‐Qiang Ju; Rui‐Hua Xu

doi:10.7150/thno.21745

Abstract

: The current study showed that GLUT1 expression was inversely correlated with sensitivity of gastric cancer cells to pharmacological ascorbate and suggested that GLUT1 expression in gastric cancer may serve as a marker for sensitivity to pharmacological ascorbate.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lu et al. (2018) studied this question.

synapsesocial.com/papers/6a995ff4d98b03152a363254 https://doi.org/10.7150/thno.21745

View Full Paper

Ask AI

Bookmark

Share

Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation

Abstract

Discussion

Cite This Study

Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation

Abstract

Discussion

Cite This Study

Keep reading

Keep reading